Effect of proton pump inhibition on acid, weakly acid and weakly alkaline gastro-esophageal reflux in children

World Journal of Pediatrics

Volumn 9, Issue 1, 2013, Pages 36-41

  Turk, Helena ^a   Hauser, Bruno ^b   Brecelj, Jernej ^a   Vandenplas, Yvan ^b   Orel, Rok ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

acid reflux; gastro esophageal reflux (disease); multichannel intraluminal impedance; pH monitoring; proton pump inhibitor

Indexed keywords

OMEPRAZOLE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COUGHING; DE MEESTER SCORE; DRUG EFFECT; DYSPHAGIA; ERUCTATION; ESOPHAGEAL PH MONITORING; ESOPHAGUS BIOPSY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; HUMAN TISSUE; IMPEDANCE; MALE; MORNING DOSAGE; ODYNOPHAGIA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; REFLUX ESOPHAGITIS; SCHOOL CHILD; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ESOPHAGEAL PH MONITORING; FEMALE; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; PROTON PUMP INHIBITORS;

EID: 84873445440     PISSN: 17088569     EISSN: 18670687     Source Type: Journal    
DOI: 10.1007/s12519-013-0405-5     Document Type: Article

References (40)

1. Sherman PM, Hassall E, Fagundes-Neto U, Gold BD, Kato S, Koletzko S, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009;104:1278-1295; quiz 1296.
2. Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, et al. North American Society for Pediatric Gastroenterology Hepatology and Nutrition, European Society for Pediatric Gastroenterology Hepatology and Nutrition. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009;49:498-547.
3. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid and gas reflux. Gut 2004;53:1024-1031. (Pubitemid 38824163)
4. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: A review of animal and human studies. Gastroenterology 1995;108:1897-1907.
5. Condino AA, Sondheimer J, Pan Z, Gralla J, Perry D, O'Connor JA. Evaluation of infantile acid and nonacid gastroesophageal reflux using combined pH monitoring and impedance measurement. J Pediatr Gastroenterol Nutr 2006;42:16-21. (Pubitemid 43061004)
6. Mousa H, Woodley FW, Metheney M, Hayes J. Testing the association between gastroesophageal reflux and apnea in infants. J Pediatr Gastroenterol Nutr 2005;41:169-177. (Pubitemid 41099364)
7. Wenzl TG, Silny J, Schenke S, Peschgens T, Heimann G, Skopnik H. Gastroesophageal reflux and respiratory phenomena in infants: status of the intraluminal impedance technique. J Pediatr Gastroenterol Nutr 1999;28:423-428. (Pubitemid 30349253)
8. Wenzl TG, Schenke S, Peschgens T, Silny J, Heimann G, Skopnik H. Association of apnea and nonacid gastroesophageal reflux in infants: Investigations with the intraluminal impedance technique. Pediatr Pulmonol 2001;31:144-149.
9. Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: A multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006;55:1398-1402. (Pubitemid 44476780)
10. Tutuian R, Mainie I, Agrawal A, Adams D, Castell DO. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 2006;130:386-391. (Pubitemid 44267004)
11. Becker V, Bajbouj M, Waller K, Schmid RM, Meining A. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow up study of intraluminal-impedance guided therapy. Aliment Pharmacol Ther 2007;26:1355-1360. (Pubitemid 350045618)
12. Iwakiri K, Kawami N, Sano H, Tanaka Y, Umezawa M, Kotoyori M, et al. Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: A study using combined pH-impedance monitoring. J Gastroenterol 2009;44:708-712.
13. Zerbib F, Roman S, Ropert A, des Varannes SB, Pouderoux P, Chaput U, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: A study in patients off and on therapy. Am J Gastroenterol 2006;101:1956-1963. (Pubitemid 44337616)
14. Gillen D, McColl KE. Problems related to acid rebound and tachyphylaxis. Best Pract Res Clin Gastroenterol 2001;15:487-495. (Pubitemid 32590881)
15. Deal L, Gold BD, Gremse DA, Winter HS, Peters SB, Fraga PD, et al. Age-specific questionnaires distinguish GERD symptom frequency and severity in infants and young children: development and initial validation. J Pediatr Gastroenterol Nutr 2005;41:178-185. (Pubitemid 41099365)
16. Lundell LR, Dent J, Bennet JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180. (Pubitemid 29333764)
17. Hassall E. Macroscopic versus microscopic diagnosis of reflux esophagitis: erosions or eosinophils? J Pediatr Gastroenterol Nut 1996;22:321-325. (Pubitemid 26098186)
18. Vandenplas Y, Belli D, Boige N, Bouquet J, Cadranel S, Cezard JP, et al. A standardized protocol for the methodology of esophageal pH monitoring and interpretation of the data for the diagnosis of gastroesophageal reflux (ESPGHAN society statement). J Pediatr Gastroenterol Nutr 1992;14:467-471.
19. Zerbib F, des Varannes SB, Roman S, Pouderoux P, Artigue F, Chaput U, et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 2005;22:1011-1021. (Pubitemid 41634884)
20. Pilic D, Fröhlich T, Nöh F, Pappas A, Schmidt-Choudhury A, Köhler H, et al. Detection of gastroesophageal reflux in children using combined multichannel intraluminal impedance and pH measurement: data from the German Pediatric Impedance Group. J Pediatr 2011;158:650-654.
21. Gilger MA, Tolia V, Vandenplas Y, Youssef NN, Traxler B, Illueca M. Safety and tolerability of esomeprazole in children with GERD. J Pediatr Gastroenterol Nutr 2008;46:524-533.
22. Gold BD. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007;45:520-529. (Pubitemid 350307136)
23. Lee JH, Kim MJ, Lee JS, Choe YH. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children. Arch Dis Child 2011;96:9-13.
24. Ward RM, Kearns GL, Tammara B, Bishop P, O'Gorman MA, James LP, et al. A multicenter, randomized, open-label, pharmacokinetics and safety study of Pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease. J Clin Pharmacol 2011;51:876-887.
25. Salvatore S, Arrigo S, Luini C, Vandenplas Y. Esophageal impedance in children: symptom-based results. J Pediatr 2010;157:949-954.
26. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001;120:1588-1598.
27. Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? Am J Gastroenterol 2008;103:2446-2453.
28. Frazzoni M, Savarino E, Manno M, Melotti G, Mirante VG, Mussetto A, et al. Reflux patterns in patients with short-segment Barret's oesophagus: A study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther 2009;30:505-515.
29. Orr WC, Craddock A, Goodrich S. Acidic and non-acidic reflux during sleep under conditions of powerful acid suppression. Chest 2007;131:460-465. (Pubitemid 46280406)
30. Marshall RE, Anggiansah A, Manifold DK, Owen WA, Owen WJ. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus. Gut 1998;43:603-606. (Pubitemid 28520091)
31. Netzer P, Gut A, Brundler R, Gaia C, Halter F, Inauen W. Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. Aliment Pharmacol Ther 2001;15:1375-1384. (Pubitemid 32835544)
32. Orel R, Brecelj J, Homan M, Heuschkel R. Treatment of oesophageal bile reflux in children: The results of a prospective study with omeprazole. J Pediatr Gastroenterol Nutr 2006;42:376-383. (Pubitemid 43841019)
33. Loots CM, Van Wijk MP, Smits MJ, Wenzl TG, Benninga MA, Omari TI. Measurement of mucosal conductivity by MII is a potential marker of mucosal integrity restored in infants on acidsuppression therapy. J Pediatr Gastroenterol Nutr 2011;53:20-23.
34. Kessing BF, Bredenoord AJ, Weijenborg PW, Hemmink GJ, Loots CM, Smout AJ. Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol 2011;106:2093-2097.
35. Johnson DA, Levy BH 3rd. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors. Expert Opin Pharmacother 2010;11:1541-1548.
36. Labenz J. Facts and fantasies in extra-oesophageal symptoms in GORD. Best Pract Res Clin Gastroenterol 2010;24:893-904.
37. Tsoukali E, Sifrim D. The role of weakly acidic reflux in proton pump inhibitor failure, has dust settled? J Neurogastroenterol Motil 2010;16:258-264.
38. Miyamoto M, Manabe N, Haruma K. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy. Intern Med 2010;49:1469-1476.
39. Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO. Combined mutichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006;93:1483-1487. (Pubitemid 44893649)
40. del Genio G, Tolone S, del Genio F, Rossetti G, Brusciano L, Pizza F, et al. Total fundoplication controls acid and nonacid reflux: evaluation by pre- and postoperative 24-h pH-multichannel intraluminal impedance. Surg Endosc 2008;22:2518-2523.